Pfizer

Stories 161 - 180 | << Prev   Next >>

Pfizer Hopes to Sell Lipitor Over the Counter

But FDA is leery about letting people use statins on their own

(Newser) - Pfizer hopes to sell an over-the-counter version of its popular cholesterol drug Lipitor, the Wall Street Journal reports. But first it will have to convince a skeptical FDA, which is wary about letting people use such statins without a doctor's supervision. Pfizer loses the patent on Lipitor in November,...

FDA: Chickens Contain Arsenic
 FDA: Chickens Contain Arsenic 
Jun 9, 2011 9:15 AM CDT

FDA: Chickens Contain Arsenic

Maker of arsenic-laced food to suspend sales

(Newser) - Pfizer has suspended sales of an arsenic-laced drug that’s been fed to chickens for decades, after the FDA released a study showing that the arsenic winds up in parts of the chicken that consumers eat. The FDA stressed that chicken meat probably doesn’t contain enough arsenic to pose...

Google CEO Eyed as Commerce Secretary

Pfizer head, Ron Kirk also in running, say sources

(Newser) - The Obama administration is considering naming Google CEO Eric Schmidt as commerce secretary, sources tell BusinessWeek . Pfizer CEO Jeffrey Kindler and current US trade representative Ron Kirk are also reportedly in the running. Current Commerce Secretary Gary Locke is being nominated to be US ambassador to China. Presidents often look...

Pfizer CEO Jeffrey Kindler Replaced in Surprise Move

Unexpected move likely ouster: analysts

(Newser) - Pfizer abruptly replaced its CEO and chairman yesterday, saying Jeffrey B. Kindler was retiring after 4.5 years leading the world's biggest drugmaker to "recharge." Analysts saw the unexpected departure as an ouster, however, coming amid repeated failures from Pfizer's labs to produce new, much-needed blockbuster drugs, multiple...

Disgraced Doctors Land at Big Pharma
 Disgraced Doctors 
 Land at Big Pharma 

investigation
Oct 19, 2010 7:59 AM CDT

Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

(Newser) - Pharmaceutical companies say they hire highly respected doctors as their white-coat sales force, peddling their drugs to other physicians. But a Pro Publica investigation has discovered that hundreds of these pitchmen have been accused of professional misconduct, been disciplined by state boards, or lacked credentials. Medical board records in the...

GOP's 'Pledge' Written by Former Oil, Pharma Lobbyist

Boehner aide lobbied for AIG, Exxon, Pfizer, Chamber of Commerce

(Newser) - The new “ Pledge to America ” the GOP intends to unveil today, as a kind of sequel to the "Contract with America" of old, was written by a guy who was, until a few months ago, a lobbyist for insurance giant AIG, along with big oil and pharma...

Kids' Form of Viagra to Treat Lung Disease

In return, Pfizer gets another 6 months for patent on adult drug

(Newser) - Pfizer plans to produce a form of Viagra designed to treat a rare form of lung disease in children. Doctors can use Viagra's well-known ability to modify blood flow to treat sufferers of pulmonary arterial hypertension, a disorder in which a child suffers from unusually high blood pressure in the...

Scientists Hail Advances on Melanoma, Lung Cancer

New drugs show significant promise for treatment

(Newser) - Scientists say they've made notable progress against two of the most difficult cancers to treat—lung cancer and melanoma, reports the New York Times . On lung cancer, a drug in study of 82 people shrank the tumors of most participants, a result so remarkable that it will be featured at...

Big Pharma Flouts Laws on Off-Label Uses

Billions in fines don't stop illegal promotion

(Newser) - Back in 2004, a unit of drug giant Pfizer pleaded guilty to marketing a drug, Neurotonin, for unapproved uses, paid $430 million in fines, and promised to clean up its act—which it had no intention of doing. "At the very same time Pfizer was in our office negotiating...

Pfizer Pays Record $2.3B Fine for False Marketing

(Newser) - Pfizer will shell out $2.3 billion—a record for a health care fraud settlement—over deceptive marketing of its drugs, the Los Angeles Times reports. Pfizer and one of its subsidiaries marketed four drugs based on off-label uses specifically prohibited by the FDA. The settlement with the Justice Department...

Drug Giants Target Cancer
 Drug Giants Target Cancer 
Sep 2, 2009 2:16 AM CDT

Drug Giants Target Cancer

Scientific advances, potentially huge profits attract Big Pharma to cancer fight

(Newser) - Major drug companies are tying their fortunes to cancer like never before, the New York Times reports. The firms—inspired by advancements in science as well as the high prices cancer drugs command—are pouring unprecedented resources into the search for new cancer drugs. The drug giants hope cancer treatments...

Tech Snaps Nadaq's Streak; Dow Climbs 24

Amazon, Microsoft fall after weak earnings

(Newser) - The tech sector exerted downward pressure on stocks today, snapping the Nasdaq’s 12-day winning streak, the Wall Street Journal reports. Microsoft sank 8.9% after reporting a 29% drop in quarterly earnings, while Amazon fell 8.3% after also reporting a disappointing quarter. Alcoa, Pfizer, and Merck helped the...

Stocks Tread Water; Dow Up 5
 Stocks Tread Water; Dow Up 5 
MARKETS
Jul 9, 2009 3:12 PM CDT

Stocks Tread Water; Dow Up 5

Goldman Sachs rises, Pfizer falls

(Newser) - The stock market indices swung back and forth across a narrow range today as financials enjoyed advances but the health care sector declined, the Wall Street Journal reports. Goldman Sachs was up 3.69% after Bank of American Merrill Lynch upgraded Goldman shares from “neutral” to “buy.”...

Anti-Smoking Chantix, Zyban Pose Suicide Risk: FDA

Smokers with mental illnesses should avoid them, agency says

(Newser) - The Food and Drug Administration is warning smokers about serious mental-illness risks of two smoking-cessation drugs, as reported suicides among their users increase. Chantix and Zyban must now carry the agency’s strongest warning label, the New York Times reports. The FDA isn’t trying to scare patients, an official...

Oil, Banks Steal 63 From Dow
 Oil, Banks Steal 63 From Dow 
MARKETS
May 15, 2009 3:13 PM CDT

Oil, Banks Steal 63 From Dow

(Newser) - Markets were off today on falling oil prices and a poor showing from the financial industry, the Wall Street Journal reports. The S&P energy index fell 2.4% and Bank of America, Pfizer, and Wal-Mart also saw declines. General Motors, whose low share price no longer significantly affects markets,...

Pfizer Offers Free Lipitor, Viagra to Jobless

70 drugs available to those who lost jobs since Jan. 1

(Newser) - Pfizer is unveiling a new program that will let people who have lost their jobs and health insurance keep taking some of its medications—including Lipitor and Viagra—for free for up to a year. The world’s biggest drugmaker will provide more than 70 of its prescription drugs free...

Drugs, Oil Push Dow Up 50
 Drugs, Oil Push Dow Up 50 
MARKETS
May 12, 2009 3:15 PM CDT

Drugs, Oil Push Dow Up 50

(Newser) - Financials dipped today as firms continued stock sell-offs to finance TARP repayments, but strong performance by drug and energy companies stabilized the market, the Wall Street Journal reports. Merck and Pfizer were up as much as 2% and 6%, respectively; oil got a boost from $60 barrels. The Dow was...

Pfizer Deal's $22.5B in Loans Hasn't Unlocked Credit

$22.5B loan in deal to acquire Wyeth comes at 7-9% interest, and lenders can walk

(Newser) - Think Pfizer’s $68 billion deal to buy Wyeth, financed in part with $22.5 billion in loans, means credit markets have thawed? Think again, the Wall Street Journal reports. Pfizer’s lenders—including JPMorgan, Bank of America, Goldman, and Citigroup—are charging high interest (7%-9%, with loans due in...

Dow Ticks Up 38 Amid Layoffs
 Dow Ticks Up 38 Amid Layoffs 
MARKETS
Jan 26, 2009 3:16 PM CST

Dow Ticks Up 38 Amid Layoffs

Home sales report boosts stocks

(Newser) - Stocks closed with mild gains today even as US firms announced roughly 50,000 job cuts, the Wall Street Journal reports. The market was buoyed by a report that home sales are picking up as buyers take advantage of low prices. The Dow closed up 38.47 at 8,116....

Stocks Shrug Off Job Losses
 Stocks Shrug Off Job Losses 
MARKET open
Jan 26, 2009 8:58 AM CST

Stocks Shrug Off Job Losses

Pfizer deal drives gains

(Newser) - Pfizer’s massive deal to buy Wyeth helped investors shrug off the bloodbath at Caterpillar, Home Depot and Sprint-Nextel this morning, sending indexes slightly higher at the open. The Dow rose 55 points, while the S&P and Nasdaq rose 11 and 18 points respectively. Caterpillar fell 10% pre-market after...

Stories 161 - 180 | << Prev   Next >>